Keywords: b-ms/pfizer, anti-clotting, drug, shows, promise, apixaban, being

B-MS/Pfizer anti-clotting drug shows promise

Article | 16 July 2007

Print This

The anti-clotting drug apixaban which is being developed by USA-based drug majors Bristol-Myers Squibb and Pfizer, has met its primary ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in